resveratrol has been researched along with Cardiac Toxicity in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 14 (48.28) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, LF; Jin, KT; Lan, HR; Li, XM | 1 |
| Abdelgaid, HA; Eleyan, M; Gamil, NM; Ibrahim, KA; Mohamed, RA | 1 |
| Cao, C; Chen, O; Gao, T; Gu, J; Guo, Y; Li, J; Liu, Q; Lu, G; Mao, M; Tang, Y; Wang, J; Xiao, M; Zhang, J; Zhang, X | 1 |
| Li, D; Song, C; Zhang, J; Zhao, X | 1 |
| Hu, J; Jiang, X; Liu, J; Sun, X; Wang, J; Zhou, W; Zhu, H | 1 |
| Al-Hussaniy, HA; Al-Samydai, AM; Al-Tameemi, ZS; Al-Zobaidy, MAJ; Alburghaif, AH; Alkhafaje, Z; Alkuraishy, HM; Azam, F; Mostafa-Hedeab, G; Naji, MA | 1 |
| Boshra, SA | 1 |
| Timm, KN; Tyler, DJ | 1 |
| Al Omar, SY; E, MP; Kodidhela, LD; Mohammad, A; S, M; Shaik, AH | 1 |
| Ahmad, R; Alanazi, A; Alhusaini, A; Fadda, L | 1 |
| Aniagu, S; Chen, T; Huang, Y; Ji, C; Jiang, Y; Ren, F; Tao, Y | 1 |
| El-Kadi, AOS; Shoieb, SM | 1 |
| Alam, AS; Dyck, JRB; Eisenstat, DD; Ferdaoussi, M; Maayah, ZH; Matsumura, N; Soni, S; Takahara, S; Zordoky, BN | 1 |
| Abou Elfadl, SG; Ammar, HI; Dhingra, S; Rashed, LA; Rub, EA; Saravanan, S; Shamaa, AA; Shoukry, HS; Zikri, MB | 1 |
| Huang, Z; Kong, J; Qiu, Y; Shen, F; Wang, L; Wang, W; Xiong, Z; Yang, Y | 1 |
| Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN | 1 |
| He, J; Li, J; Liu, F; Liu, J; Liu, Y; Qi, Z; Shen, Y; Sumi, S; Tian, W; Yang, L; Zhang, Q | 1 |
| Alani, AWG; Cote, B; Fatease, AA; LeBlanc, N; Nguyen, DX; Rao, DA; Shah, V | 1 |
| Alani, AW; Carlson, LJ; Cote, B; Rao, DA | 1 |
| Abd-Elaziz, HR; Arafa, MH; Atteia, HH; Mohammad, NS | 1 |
| Al-Harthi, SE; Al-Kreathy, HM; Alaama, MN; Alarabi, OM; Damanhouri, ZA; Khan, LM; Osman, AM; Ramadan, WS | 1 |
| Guo, FF; Huang, T; Li, BX; Liu, C; Liu, LR; Yan, CC; Zhang, KP; Zhao, X; Zhu, QL | 1 |
| Chan, LW; Rudd, JA; Sin, TK; Siu, PM; Tam, BT; Wong, CS; Ying, M; Yip, SP; Yung, BY | 1 |
| Alani, AWG; Carlson, LJ; Cote, B; Rao, DA | 1 |
| Gu, J; Hu, W; Zhang, DD | 1 |
| Cao, J; Chen, Y; Fu, L; Li, Y; Lou, Y; Sun, J; Wang, Z; Xu, Y; Zhou, P | 1 |
| Chan, LW; Rudd, JA; Sin, TK; Siu, PM; Tam, BT; Wong, CS; Yip, SP; Yu, AP; Yung, BY | 1 |
| Chen, YG; Gu, J; Hu, W; Song, ZP; Wang, CQ; Zhang, DD | 1 |
| Barani, AK; Hashemzaei, M; Iranshahi, M; Rezaee, R; Tabrizian, K; Tsarouhas, K; Tsatsakis, AM; Wilks, MF | 1 |
4 review(s) available for resveratrol and Cardiac Toxicity
| Article | Year |
|---|---|
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiotoxicity; Doxorubicin; Humans; Resveratrol | 2021 |
Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs.
Topics: Anthracyclines; Antineoplastic Agents; Cardiotoxicity; Dexrazoxane; Digoxin; Humans; Polyketides; Resveratrol | 2023 |
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones | 2020 |
Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity.
Topics: Animals; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Humans; Myocytes, Cardiac; Phytoalexins; Resveratrol; Sesquiterpenes; Stilbenes | 2015 |
25 other study(ies) available for resveratrol and Cardiac Toxicity
| Article | Year |
|---|---|
Resveratrol alleviates cardiac apoptosis following exposure to fenitrothion by modulating the sirtuin1/c-Jun N-terminal kinases/p53 pathway through pro-oxidant and inflammatory response improvements: In vivo and in silico studies.
Topics: Acetylcholinesterase; Animals; Antioxidants; Apoptosis; Cardiotoxicity; Fenitrothion; Glutathione; JNK Mitogen-Activated Protein Kinases; Male; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuin 1; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2022 |
Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway.
Topics: Animals; Apoptosis; Cardiotoxicity; Doxorubicin; Fibroblast Growth Factor 1; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Sirtuin 1 | 2022 |
Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis.
Topics: Animals; Cardiotoxicity; Ferroptosis; Fluorouracil; Glutathione; Mice; Myocytes, Cardiac; Phospholipid Hydroperoxide Glutathione Peroxidase; Rats; Resveratrol | 2023 |
Resveratrol ameliorates penconazole-induced cardiotoxicity by inhibition of oxidative stress and apoptosis in zebrafish larvae.
Topics: Animals; Apoptosis; Cardiotoxicity; Embryo, Nonmammalian; Larva; Oxidative Stress; Resveratrol; Triazoles; Zebrafish | 2023 |
Resveratrol Modulates miR-34a in Cardiotoxicity Induced by Isoproterenol.
Topics: Animals; Cardiotoxicity; Heart; Isoproterenol; Male; MicroRNAs; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Combined cardio-protective ability of syringic acid and resveratrol against isoproterenol induced cardio-toxicity in rats via attenuating NF-kB and TNF-α pathways.
Topics: Animals; Cardiotonic Agents; Cardiotoxicity; Gallic Acid; Isoproterenol; Male; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |
Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotoxicity; Carvedilol; Caspase 3; Doxorubicin; Drug Therapy, Combination; Heart; Liposomes; Male; Myocardium; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Transforming Growth Factor beta1 | 2020 |
Resveratrol protects against PM2.5-induced heart defects in zebrafish embryos as an antioxidant rather than as an AHR antagonist.
Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Embryo, Nonmammalian; Gene Expression Regulation, Developmental; Heart; Heart Defects, Congenital; Oxidative Stress; Particulate Matter; Protective Agents; Reactive Oxygen Species; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Zebrafish; Zebrafish Proteins | 2020 |
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents | 2020 |
Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Doxorubicin; Inflammasomes; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol | 2021 |
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.
Topics: Animals; Apoptosis; Biomarkers; Cardiotoxicity; Creatine Kinase, MB Form; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Echocardiography; Heart; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Myocardium; NFATC Transcription Factors; Protective Agents; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes | 2017 |
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Cell Line; Diterpenes; Epoxy Compounds; Female; Forkhead Box Protein O3; Heart Diseases; Humans; Male; Mice; Mice, Inbred BALB C; Myocardium; Myocytes, Cardiac; Phenanthrenes; Resveratrol; Signal Transduction; Sirtuin 3; Stilbenes | 2016 |
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling | 2018 |
Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Cardiovascular Diseases; Doxorubicin; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Resveratrol; Up-Regulation; Vascular Endothelial Growth Factor B | 2020 |
Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.
Topics: Animals; Apoptosis; Cardiotoxicity; Cell Line, Tumor; Cell Survival; Curcumin; Doxorubicin; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; Luminescent Measurements; Mice; Micelles; Ovarian Neoplasms; Polymers; Quercetin; Resveratrol; Stroke Volume; Troponin I; Xenograft Model Antitumor Assays | 2019 |
Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Topics: Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cell Line; Cell Line, Tumor; Cell Survival; Curcumin; Doxorubicin; Drug Carriers; Drug Combinations; Female; Humans; Micelles; Myocytes, Cardiac; Ovarian Neoplasms; Poloxamer; Resveratrol; Stilbenes | 2014 |
Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Caspase 3; Doxorubicin; Fibrosis; Gene Expression; Glutathione; Heart; Heart Ventricles; Male; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Superoxide Dismutase; Transforming Growth Factor beta1; Ventricular Remodeling | 2014 |
Amelioration of doxorubicin‑induced cardiotoxicity by resveratrol.
Topics: Animals; Antioxidants; Cardiotoxicity; Creatine Kinase; Doxorubicin; Glutathione; Heart; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Plant Extracts; Polyphenols; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2014 |
The rescuable function and mechanism of resveratrol on As₂O₃-induced hERG K⁺ channel deficiency.
Topics: Action Potentials; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cardiotonic Agents; Cardiotoxicity; Down-Regulation; Endoplasmic Reticulum Stress; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Heart Ventricles; HEK293 Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Myocytes, Cardiac; Oxides; Patch-Clamp Techniques; Resveratrol; Stilbenes | 2014 |
Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis.
Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Doxorubicin; Heart; Mice; Myocytes, Cardiac; Oxidative Stress; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Ubiquitin-Specific Peptidase 7; Ubiquitin-Specific Proteases | 2015 |
Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Cell Line; Cell Line, Tumor; Doxorubicin; Drug Carriers; Female; Heart; Humans; Male; Micelles; Myocytes, Cardiac; Poloxamer; Quercetin; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes | 2015 |
Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Endoplasmic Reticulum Stress; Myoblasts; Rats; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
Acute Treatment of Resveratrol Alleviates Doxorubicin-Induced Myotoxicity in Aged Skeletal Muscle Through SIRT1-Dependent Mechanisms.
Topics: Age Factors; Animals; Apoptosis; Cardiotoxicity; Caspase 3; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Male; Mice; Muscle, Skeletal; Oxidative Stress; Proteasome Endopeptidase Complex; Pyruvate Dehydrogenase Complex; Random Allocation; Resveratrol; Signal Transduction; Sirtuin 1; Staining and Labeling; Stilbenes | 2016 |
Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Topics: AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Autophagy; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2016 |
Effects of resveratrol on carbon monoxide-induced cardiotoxicity in rats.
Topics: Animals; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Cardiotonic Agents; Cardiotoxicity; Caspase 3; Dose-Response Relationship, Drug; Electrocardiography; Heart; Male; Myocardium; Proto-Oncogene Proteins c-akt; Rats, Wistar; Resveratrol; Stilbenes | 2016 |